Cardiology Update

MARCH 5, 2024

In the ISCHEMIA (International Study of Comparative Health Effectiveness with Medical and Invasive Approaches) trial, researchers examined the risk of ischemic events in patients with stable coronary artery disease. years, with 57.1% occurring within 30 days after CABG. years, with 21.1% occurring within 30 days after PCI.

Coronary Artery Disease 116

Coronary Artery Disease Ischemia Coronary Artery Bypass Graft Myocardial Infarction 116

Cardiovascular Diabetology

JULY 10, 2024

Background The effect of empagliflozin, a sodium-glucose-co-transporter-2 inhibitor, on risk for myocardial infarction has not been fully characterized. MIs could be assigned to > 1 type.

Myocardial Infarction 52

Myocardial Infarction Coronary Artery Bypass Graft Outcomes Plaque 52

Frontiers in Cardiovascular Medicine

JANUARY 15, 2024

Background Contemporary management of spontaneous coronary artery dissection (SCAD) is still controversial. This systematic review of the literature aims to explore outcomes in the patients treated with conservative management vs. invasive strategy. Approximately 48.5% There were initially 65.2%

SCAD 75

SCAD Coronary Artery Bypass Graft Outcomes Myocardial Infarction 75

Frontiers in Cardiovascular Medicine

JANUARY 7, 2024

Background Redo sternotomy aortic root surgery is technically demanding, and the evidence on outcomes is mostly from retrospective, small sample, single-centre studies. We report the trend, early clinical results and outcome predictors of redo aortic root replacement over 20 years in the United Kingdom. Age >59 (OR: 2.99, CI: 1.92–4.65,

Coronary Artery Bypass Graft 69

Coronary Artery Bypass Graft Aortic Hospital Outcomes 69

American College of Cardiology

DECEMBER 5, 2024

What are the long-term outcomes of percutaneous coronary intervention (PCI) versus coronary artery bypass grafting (CABG) in patients with non-ST-segment elevation myocardial infarction (NSTEMI) and multivessel disease?

Coronary Artery Bypass Graft 40

Coronary Artery Bypass Graft Myocardial Infarction Outcomes Article 40

Journal of the American Heart Association

MARCH 13, 2025

Cox proportional hazard regression was used to evaluate the effect of Lp(a) on AVR, AVR or cardiac death, and valvular or cardiovascular events (AVR, cardiac death, myocardial infarction, stroke, heart failure, or coronary artery bypass grafting). The maximal followup time was set to 5 years.

Aortic valve 45

Aortic valve Coronary Artery Bypass Graft Stenosis Aortic 45

Frontiers in Cardiovascular Medicine

FEBRUARY 23, 2024

Introduction The presence of non-coronary atherosclerosis (NCA) in patients with coronary artery disease is associated with a poor prognosis. We have studied whether NCA is also a predictor of poorer outcomes in patients undergoing coronary artery bypass grafting (CABG).

Coronary Artery Bypass Graft 64

Coronary Artery Bypass Graft Atherosclerosis Peripheral Arterial Disease Coronary Artery Disease 64

Circulation

NOVEMBER 11, 2024

This study investigates the relationship between baseline 5-HTP levels and the incidence of major adverse cardiovascular events (MACE) in patients who have experienced ST-elevation myocardial infarction (STEMI).Objective:Our years, 53 women) followed for up to 15 years.

Myocardial Infarction 40

Myocardial Infarction Coronary Artery Bypass Graft STEMI Angina 40

Circulation: Cardiovascular Quality & Outcomes

FEBRUARY 6, 2024

Circulation: Cardiovascular Quality and Outcomes, Ahead of Print. Patients who had an myocardial infarction, underwent coronary artery bypass graft (hazard ratio, 1.60 [95% CI, 1.55–1.65]), Each type of ASCVD event was associated with an increased likelihood of smoking.

Coronary Artery Bypass Graft 45

Coronary Artery Bypass Graft Outpatient Peripheral Arterial Disease Cardiovascular Disease 45

Circulation

NOVEMBER 11, 2024

The primary outcome was to estimate the prevalence of cardiovascular risk factors in patients with hemophilia compared to the general population. Further research is to identify potential ex-specific risk factors that predispose to worse cardiovascular outcomes among patients with hemophilia.

Risk Factors 40

Risk Factors Cardiovascular Disease Coronary Artery Bypass Graft Outcomes 40

Journal of the American Heart Association

JANUARY 10, 2025

The primary outcome was risk of an ASCVD hospitalization composite outcome (myocardial infarction, coronary artery bypass graft, percutaneous coronary intervention, stroke, transient ischemic accident) after COPD hospitalization relative to before COPD hospitalization. P0.0001).

Coronary Artery Bypass Graft 45

Coronary Artery Bypass Graft Cardiovascular Disease Hospital Pulmonary 45

Journal of the American Heart Association

FEBRUARY 24, 2025

Differenceindifferences analyses were used to compare differences in outcomes before (20142015) and after (20182019; 2year CR period=20162017) the CR period between participants and nonparticipants.ResultsWe identified 57 668 CReligible beneficiaries after matching, with equal numbers of participants and nonparticipants.

Medicare 45

Medicare Coronary Artery Bypass Graft Cardiac Rehabilitation Inpatient 45

Journal of the American Heart Association

JANUARY 16, 2024

The primary outcome is the mean difference between the intervention versus control groups in distance walked on the 6‐minute walk test (ie, functional capacity) at 12 weeks post randomization.

Coronary Artery Bypass Graft 40

Coronary Artery Bypass Graft Technology Cardiac Rehabilitation Quality of Life 40

Cardiometabolic Health Congress

FEBRUARY 1, 2024

A rate of 15% of major depressive disorder has been reported in patients after myocardial infarction or coronary artery bypass grafting, and this rate is >20% in patients with heart failure and is much higher in advanced heart failure.”

Cardiovascular Disease 105

Cardiovascular Disease Coronary Artery Bypass Graft Heart Disease Risk Factors 105

Dr. Smith's ECG Blog

JULY 31, 2018

This is diagnostic of myocardial infarction. Spontaneous Coronary Artery Dissection Spontaneous coronary artery dissection (SCAD) is an infrequent but increasingly recognized cause of acute coronary syndrome (1- 4%) 1 , most commonly affecting women (90%) 2. She felt more comfortable being admitted.

SCAD 52

SCAD Chest Pain Myocardial Infarction Ischemia 52

Circulation

FEBRUARY 13, 2025

Due to the limited number of ischemic stroke and cardiac arrest cases among AAS users, these outcomes were not reportable.CONCLUSIONS:AAS use is associated with a substantially increased risk of cardiovascular disease in a large cohort with a long follow-up period.

Coronary Artery Bypass Graft 84

Coronary Artery Bypass Graft Cardiovascular Disease Cardiac Arrest Myocardial Infarction 84

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Adult Cardiac Surgery Database Lead Author Title Publication Date Jacob Raphael Red Blood Cell Transfusion and Pulmonary Complications: The Society of Thoracic Surgeons Adult Cardiac Surgery Database Analysis The Annals of Thoracic Surgery January 2024 Joseph Sabik Multi-Arterial versus Single-Arterial Coronary Surgery: Ten Year Follow-up of One Million (..)

Research 52

Research Coronary Artery Bypass Graft Aortic valve Congenital 52

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Program Designations Access and Publications (A&P) 1 Participant User File (PUF) 2 Task Force on Funded Research (TFR) 3 Special Projects 4 Adult Cardiac Surgery Database Lead Author Title Publication Date William Keeling 2 National Trends in Emergency Coronary Artery Bypass Grafting European Journal of Cardiothoracic Surgery October 2023 Jake (..)

Research 52

Research Coronary Artery Bypass Graft Aortic valve Congenital 52

Frontiers in Cardiovascular Medicine

DECEMBER 13, 2023

Introduction Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) have been linked to clinical outcomes in patients with coronary artery disease (CAD). However, the prognostic value of TIMP-1 in patients with CAD who underwent coronary artery bypass grafting (CABG) has not been elucidated.

Coronary Artery Bypass Graft 64

Coronary Artery Bypass Graft Coronary Artery Disease Myocardial Infarction Cholesterol 64

Open Heart

OCTOBER 7, 2024

Background Takotsubo cardiomyopathy (TC) is an established differential diagnosis of myocardial infarction with non-obstructive coronaries with significant interest but limited data on prognostication. We reviewed the characteristics and in-hospital outcomes and developed a novel risk score for TC.

Inpatient 52

Inpatient Coronary Artery Bypass Graft Cardiomyopathy Cardiogenic Shock 52

Circulation: Cardiovascular Quality & Outcomes

FEBRUARY 8, 2024

Circulation: Cardiovascular Quality and Outcomes, Ahead of Print. BACKGROUND:Sex differences in acute myocardial infarction treatment and outcomes are well documented, but it is unclear whether differences are consistent across countries. for males; Israel percutaneous coronary intervention in 2018, 76.7%

Myocardial Infarction 40

Myocardial Infarction Coronary Artery Bypass Graft Hospital STEMI 40

Circulation

NOVEMBER 11, 2024

Introduction:Atrial fibrillation (AF) is a common cardiac arrhythmia, the risk of cardiovascular adverse outcome rises when it coexists with acute coronary syndrome (ACS) or undergoing percutaneous coronary intervention (PCI).

Atrial Fibrillation 40

Atrial Fibrillation Coronary Artery Bypass Graft Coronary Artery Disease Myocardial Infarction 40

MIBHS

DECEMBER 13, 2024

One of the most effective treatments for severe coronary artery disease, a type of cardiovascular disease, is coronary artery bypass grafting (CABG), a procedure designed to restore blood flow to the heart. But does coronary artery bypass surgery also improve erectile capacity?

Coronary Artery Bypass Graft 52

Coronary Artery Bypass Graft Diet Heart Disease Risk Factors 52

Frontiers in Cardiovascular Medicine

MARCH 17, 2025

Coronary artery bypass grafting (CABG) is a common and effective treatment for patients with complex coronary artery disease. This case report discusses a 75-year-old male patient who presented with angina and shortness of breath due to thrombus formation in a venous graft 20 years after CABG.

Coronary Artery Bypass Graft 52

Coronary Artery Bypass Graft Thrombolysis Coronary Artery Disease Myocardial Infarction 52

Frontiers in Cardiovascular Medicine

MARCH 3, 2025

Primary endpoints included overall mortality, cardiac-related mortality, stroke, myocardial infarction, repeat revascularization. TTFM demonstrated superior flow rates in artery-on-vein grafts [50 (4070) ml/min] compared to vein-on-vein grafts [40 (3053.5), p<0.001].ConclusionsWhen

Coronary Artery Bypass Graft 52

Coronary Artery Bypass Graft Strokes Stroke Aortic 52